More patients to move towards non-traditional hospital settings for global
endometrial ablation and benign prostatic hyperplasia procedures, according
to Millennium Research Group
WALTHAM, Mass., May 13 /PRNewswire/ -- Millennium Research Group's
(MRG's) Urology/Gynecology Marketrack(TM) results indicate a potential for
movement in global endometrial ablation (GEA) and benign prostatic
hyperplasia (BPH) procedures from hospitals to ambulatory surgical centers
(ASCs) and offices. Over 80% of urology and over 70% of gynecology
procedures tracked in Q4 2007 were performed in hospitals. MRG expects that
these numbers will begin to shift to ASCs and office settings over time,
providing additional market potential if manufacturers can implement
effective marketing strategies targeting these settings.
In November 2007, the Centers for Medicare & Medicaid Services (CMS)
announced favorable reimbursement for various urology and gynecology
procedures performed in ASCs and offices rather than in traditional
hospital settings. In addition to the new ASC and office-based
reimbursement structure, which took effect in 2008, there is a great deal
of upside potential in this market given that doctors are capable of
performing higher procedure volumes in-office, unlike in a hospital
setting, where they have to compete for operating room space. The physician
office setting can also be more comfortable than a hospital, making more
patients willing to undergo procedures in-office.
"The reimbursement shift may encourage physician and patient adoption
of in-office GEA or BPH procedures, expanding the number of facilities
performing them," says Nadia Lachowsky, Senior Marketrack(TM) Analyst at
Millennium Research Group, "However, the successful transition of GEA and
BPH to the office setting must be facilitated by various manufacturers in
the market. Device manufacturers will need to provide extensive support to
doctors who wish to adopt the procedure, including treatment advice,
procedural training, advertising campaigns, and business/practice
management support."
Millennium Research Group will be attending the American Urological
Association (AUA) annual meeting in Orlando, Florida from May 17 to 20.
Come to booth #3031 for a preview of the Urology/Gynecology Marketrack(TM)
data.
About Urology/Gynecology Marketrack(TM)
Urology/Gynecology Marketrack(TM) gathers data from over 300 hospitals,
ASCs, and urology and gynecology offices throughout the US on a quarterly
basis. Product categories covered include female sterilization, GEA,
endometrial resection, vaginal slings, pelvic floor reconstruction, BPH,
and kidney stone management. Marketrack(TM) subscribers receive thousands
of data points, including usage (units, average selling prices, and
revenues), procedure, competitor, and brand-level information.
About Millennium Research Group
Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc.
company (http://www.DecisionResources.com), is the global authority on medical
technology market intelligence and a leading provider of strategic
information to the health care sector. Focused solely on the medical
device, pharmaceutical, and biotechnology industries, the company provides
its clients with the benefits of its specialized industry expertise through
published reports and customized consulting services.
All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net
SOURCE Millennium Research Group
 back to top
Related links:
http://www.mrg.net
http://www.DecisionResources.com
CONTACT:
Amy Krohn of Millennium Research Group,
+1-416-364-7776 x101, akrohn@mrg.net
|
